Updates
We bring together news, announcements and other updates from around Global Fund in this section. You can receive a notification every time a new update is published by using our really simple syndication (RSS) feed. See our RSS Feeds page for more information.
-
The Global Fund is very pleased to announce the appointment of Katie Kampf as its new Chief of Staff, starting on 14 August 2023.
-
The WHO and the Global Fund have signed a new and revised Strategic Framework for Collaboration, designed to build stronger and more resilient health systems and maximize collaboration and impact in support of country, regional and global responses t...
-
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD).
-
16 December 2022
Global Fund appoints Marijke Wijnroks as Head of Strategic Investment and Impact Division
The Global Fund to Fight AIDS, Tuberculosis and Malaria is pleased to announce the appointment of Marijke Wijnroks as the Head of the Strategic Investment and Impact Division. -
16 December 2022
TERG: Thematic Evaluation of the Global Fund’s Performance in Challenging Operating Environments (COE)
The Technical Evaluation Reference Group (TERG), upon request by the Global Fund's Strategy Committee, undertook an evaluation of the Global Fund’s implementation of its Challenging Operating Environments (COE) Policy, which was approved by the Board... -
30 November 2022
TERG: Evaluation of Accelerating the Equitable Deployment of and Access to Innovations
The Technical Evaluation Reference Group (TERG) evaluated how the Global Fund is performing on accelerating the equitable deployment of and access to innovations, and how its investments complement the work of other global health partners. -
19 October 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). -
The Board of the Global Fund to Fight AIDS, Tuberculosis and Malaria has formally launched the process for selecting its next Chair and Vice-Chair for a 3-year term from 2023-2026, to succeed the current Board Leadership, whose terms expire in May 20...
-
The Global Fund is very pleased to announce the appointment of John Grove as its new Chief Evaluation and Learning Officer, starting on 1 October 2022.
-
The Global Fund is pleased to announce the appointment of Susanne Kuehn as the new Ethics Officer and Head of the Ethics Office.
-
-
The Global Fund to Fight AIDS, Tuberculosis and Malaria has been included in the ‘Good’ category in a leading international aid transparency index published today.
-
-
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an expression of interest to have their products evaluated by the Expert Review Panel for Diagnostics.
-
The following products have been recommended for use by the Expert Review Panel (ERP): Rifapentine 300mg tablets Al/Al strip pack manufactured by Lupin, India; Rifapentine/Isoniazid 300/300mg Al/Al strip pack manufactured by Lupin, India
-
03 May 2022
Global Fund Appoints Susie Rhee as General Counsel and Head of the Legal & Governance Department
The Global Fund is pleased to announce the appointment of Susie Rhee as the new General Counsel and Head of the Legal & Governance Department. -
08 April 2022
Opportunity for Evaluation of Diagnostic Products
The Global Fund and Unitaid are inviting manufacturers of diagnostic products to submit an Expression of Interest (EoI) to have their products evaluated by the Expert Review Panel for Diagnostics (ERPD). This evaluation will focus particularly on dia... -
The Global Fund, in collaboration with The Rockefeller Foundation, is supporting efforts to strengthen national health information and surveillance systems through the Data Science Catalytic Fund (DSCF) in Rwanda, Uganda, Ethiopia and Burkina Faso. -
17 March 2022
Global Health Supply Chain Dialogue
The Global Fund is organizing a Global Health Supply Chain Dialogue from 29 to 31 March 2022 under the theme “Building Resilient Supply Chains for Effective Pandemic Preparedness”. -
Following an LFA verification of a Recipient’s procurement, the QA Team would like to bring to the attention of the procurement community that certain Personal Protective Equipment (PPE) products and medical devices, and related documents, prominentl...